Clinical
Risperidone: take extra care
The TGA has been receiving increased reports of paediatric dosing error with risperidone “We received 22 adverse event reports in 2024 involving the overdose of risperidone oral solution in Australian …
TGA issues updated warnings for RSV vaccines
Safety information for two RSV vaccines is being updated to “reflect the low risk of people contracting Guillain-Barre syndrome following vaccination Immunisers are being advised to be aware of the …
May MIMS update
Some of the recent changes to the medicines landscape, with new products, indications, contraindications, presentations and safety related changes New Products Dexrazoxane (Dexrazoxane-Reach) is an analogue of ethylene diamine tetra-acetic …
Palliative project to support stakeholders
Access to core palliative care medicines needed for people receiving end-of-life care The Pharmaceutical Society of Australia (PSA) has joined up as part of a new consortium led by Palliative …
Is the tide turning on vapes?
A pharmacy ordering company says it’s seen a surge in demand for nicotine vapes through its platform In an update to investors, listed microcap Pharmx reported an almost 500% increase …
AI ‘hindered’ by concerns over privacy, ethics
AI could help predict adverse drug reactions in hospitals, a new study says, but Alfred Health’s chief pharmacy information officer believes more evaluation is needed Artificial intelligence (AI) and machine …
‘I’ve seen lots of patients doing that’
People are “microdosing” weight loss drugs mainly due to cost or availability… a pharmacist and a GP who see this frequently share how they respond People are “microdosing” weight loss …
Supporting more contraceptive options for women
PBAC recommends new PBS listings for oral contraception plus treatment of atopic dermatitis and severe asthma in children The PBAC has recommended listing estetrol with drospirenone (Nextstellis) on the PBS …
Unlawful use of VAD substance: an ‘isolated’ incident?
Governments should consider measures that reduce harms from private self‐administration following coroner’s case, say experts Health law researchers have recommended consideration of measures to reduce harms associated with private self‐administration …
April MIMS update
Some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products Momelotinib (as dihydrochloride monohydrate) (Omjjara) and its major circulating metabolite (M21) are inhibitors …
Downscheduling rejected
A leading vaginal gel will remain as a Pharmacist Only medicine, the TGA rules, while products containing deadly nightshade will be restricted to use in young children A move to …
Next gen progestogen-only pill (POP) added to PBS
Oral contraceptive with 24-hour missed pill window added to PBS, along with combination therapy for women with fertility issues Around 80,000 Australian women paying privately for the progestogen-only oral contraceptive …